Related Experiment Videos
Crystallization of purified recombinant human interleukin-1 beta
D B Carter1, K A Curry, C S Tomich
1Molecular Biology Research, Upjohn Company, Kalamazoo, Michigan 49007.
Proteins
|January 1, 1988
Summary
Researchers cloned and expressed human interleukin-1 beta in E. coli, yielding a biologically active protein. This purified recombinant interleukin-1 beta protein has been crystallized for structural determination.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Interleukin-1 beta (IL-1 beta) is a key inflammatory cytokine.
- Understanding IL-1 beta's structure is crucial for developing targeted therapeutics.
Purpose of the Study:
- To clone and express the gene for human interleukin-1 beta.
- To purify and characterize the recombinant protein.
- To obtain crystals for structural analysis.
Main Methods:
- Gene cloning from hepatoma cellular RNA.
- High-level expression in Escherichia coli.
- Multi-step protein purification including FPLC and ion exchange chromatography.
- Crystallization via ammonium sulfate precipitation.
Main Results:
- Successfully expressed and purified biologically active recombinant human interleukin-1 beta (rIL-1 beta).
- rIL-1 beta exhibits a pI of 6.7 and molecular mass of 17,500 daltons.
- Tetragonal crystals of rIL-1 beta were obtained, suitable for X-ray diffraction to at least 2 A resolution.
Conclusions:
- The study successfully produced and purified active rIL-1 beta.
- Crystallization of rIL-1 beta provides a foundation for determining its three-dimensional structure.
- Structural insights into IL-1 beta could advance therapeutic strategies for inflammatory diseases.